HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation

Current Opinion in Immunology

Volumn 26, Issue 1, 2014, Pages 115-122

  Mellins, Elizabeth D ^a   Stern, Lawrence J ^b  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DM ANTIGEN; HLA DO ANTIGEN; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIBODY TITER; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ANTIGEN PRESENTATION; AUTOIMMUNITY; BINDING AFFINITY; BINDING SITE; CD4+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CRYSTAL STRUCTURE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROTEIN INTERACTION; REVIEW;

ANIMALS; ANTIGEN PRESENTATION; CRYSTALLOGRAPHY, X-RAY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-D ANTIGENS; HUMANS; MICE; MODELS, MOLECULAR; PEPTIDES; PROTEIN BINDING; PROTEIN ENGINEERING; STRUCTURAL HOMOLOGY, PROTEIN;

EID: 84890050541     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2013.11.005     Document Type: Review

References (55)

1. Adams E.J., Luoma A.M. The adaptable major histocompatibility complex (MHC) fold: structure and function of nonclassical and MHC class I-like molecules. Annu Rev Immunol 2013, 31:529-561.
2. Pos W., Sethi D.K., Call M.J., Schulze M.S., Anders A.K., Pyrdol J., Wucherpfennig K.W. Crystal structure of the HLA-DM-HLA-DR1 complex defines mechanisms for rapid peptide selection. Cell 2012, 151:1557-1568.
3. Guce A.I., Mortimer S.E., Yoon T., Painter C.A., Jiang W., Mellins E.D., Stern L.J. HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism. Nat Struct Mol Biol 2013, 20:90-98.
4. Sloan V.S., Cameron P., Porter G., Gammon M., Amaya M., Mellins E., Zaller D.M. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 1995, 375:802-806.
5. Vogt A.B., Kropshofer H., Moldenhauer G., Hammerling G.J. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. Proc Natl Acad Sci U S A 1996, 93:9724-9729.
6. Anders A.K., Call M.J., Schulze M.S., Fowler K.D., Schubert D.A., Seth N.P., Sundberg E.J., Wucherpfennig K.W. HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide. Nat Immunol 2011, 12:54-61.
7. Painter C.A., Negroni M.P., Kellersberger K.A., Zavala-Ruiz Z., Evans J.E., Stern L.J. Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange. Proc Natl Acad Sci U S A 2011, 108:19329-19334.
8. Kropshofer H., Arndt S.O., Moldenhauer G., Hammerling G.J., Vogt A.B. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 1997, 6:293-302.
9. Denzin L.K., Hammond C., Cresswell P. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J Exp Med 1996, 184:2153-2165.
10. Rabinowitz J.D., Vrljic M., Kasson P.M., Liang M.N., Busch R., Boniface J.J., Davis M.M., McConnell H.M. Formation of a highly peptide-receptive state of class II MHC. Immunity 1998, 9:699-709.
11. Joshi R.V., Zarutskie J.A., Stern L.J. A three-step kinetic mechanism for peptide binding to MHC class II proteins. Biochemistry 2000, 39:3751-3762.
12. Frayser M., Sato A.K., Xu L., Stern L.J. Empty and peptide-loaded class II major histocompatibility complex proteins produced by expression in Escherichia coli and folding in vitro. Protein Expr Purif 1999, 15:105-114.
13. Chou C.L., Sadegh-Nasseri S. HLA-DM recognizes the flexible conformation of major histocompatibility complex class II. J Exp Med 2000, 192:1697-1706.
14. Yoon T., Macmillan H., Mortimer S.E., Jiang W., Rinderknecht C.H., Stern L.J., Mellins E.D. Mapping the HLA-DO/HLA-DM complex by FRET and mutagenesis. Proc Natl Acad Sci U S A 2012, 109:11276-11281.
15. Pashine A., Busch R., Belmares M.P., Munning J.N., Doebele R.C., Buckingham M., Nolan G.P., Mellins E.D. Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides. Immunity 2003, 19:183-192.
16. Doebele R.C., Busch R., Scott H.M., Pashine A., Mellins E.D. Determination of the HLA-DM interaction site on HLA-DR molecules. Immunity 2000, 13:517-527.
17. Mosyak L., Zaller D.M., Wiley D.C. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation. Immunity 1998, 9:377-383.
18. Nicholson M.J., Moradi B., Seth N.P., Xing X., Cuny G.D., Stein R.L., Wucherpfennig K.W. Small molecules that enhance the catalytic efficiency of HLA-DM. J Immunol 2006, 176:4208-4220.
19. Fremont D.H., Crawford F., Marrack P., Hendrickson W.A., Kappler J. Crystal structure of mouse H2-M. Immunity 1998, 9:385-393.
20. Yin L., Calvo-Calle J.M., Dominguez-Amorocho O., Stern L.J. HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-lives. J Immunol 2012, 189:3983-3994.
21. Chaves F.A., Lee A.H., Nayak J.L., Richards K.A., Sant A.J. The utility and limitations of current Web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infection. J Immunol 2012, 188:4235-4248.
22. Schulze M.S., Anders A.K., Sethi D.K., Call M.J. Disruption of hydrogen bonds between major histocompatibility complex class II and the peptide N-terminus is not sufficient to form a human leukocyte antigen-DM receptive state of major histocompatibility complex class II. PLoS ONE 2013, 8:e69228.
23. Pos W., Sethi D.K., Wucherpfennig K.W. Mechanisms of peptide repertoire selection by HLA-DM. Trends Immunol 2013, 34:495-501.
24. Sidney J., Steen A., Moore C., Ngo S., Chung J., Peters B., Sette A. Divergent motifs but overlapping binding repertoires of six HLA-DQ molecules frequently expressed in the worldwide human population. J Immunol 2010, 185:4189-4198.
25. Hou T., Macmillan H., Chen Z., Keech C.L., Jin X., Sidney J., Strohman M., Yoon T., Mellins E.D. An insertion mutant in DQA1*0501 restores susceptibility to HLA-DM: implications for disease associations. J Immunol 2011, 187:2442-2452.
26. Kim C.Y., Quarsten H., Bergseng E., Khosla C., Sollid L.M. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci U S A 2004, 101:4175-4179.
27. Ferrante A., Gorski J. A Peptide/MHCII conformer generated in the presence of exchange peptide is substrate for HLA-DM editing. Sci Rep 2012, 2:386.
28. Ferrante A., Anderson M.W., Klug C.S., Gorski J. HLA-DM mediates epitope selection by a "compare-exchange" mechanism when a potential peptide pool is available. PLoS ONE 2008, 3:e3722.
29. Tampe R., Clark B.R., McConnell H.M. Energy transfer between two peptides bound to one MHC class II molecule. Science 1991, 254:87-89.
30. Call M.J., Xing X., Cuny G.D., Seth N.P., Altmann D.M., Fugger L., Krogsgaard M., Stein R.L., Wucherpfennig K.W. In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchange. J Immunol 2009, 182:6342-6352.
31. Marin-Esteban V., Falk K., Rotzschke O. "Chemical analogues" of HLA-DM can induce a peptide-receptive state in HLA-DR molecules. J Biol Chem 2004, 279:50684-50690.
32. Hopner S., Dickhaut K., Hofstatter M., Kramer H., Ruckerl D., Soderhall J.A., Gupta S., Marin-Esteban V., Kuhne R., Freund C., et al. Small organic compounds enhance antigen loading of class II major histocompatibility complex proteins by targeting the polymorphic P1 pocket. J Biol Chem 2006, 281:38535-38542.
33. Gupta S., Hopner S., Rupp B., Gunther S., Dickhaut K., Agarwal N., Cardoso M.C., Kuhne R., Wiesmuller K.H., Jung G., et al. Anchor side chains of short peptide fragments trigger ligand-exchange of class II MHC molecules. PLoS ONE 2008, 3:e1814.
34. Chou C.L., Mirshahidi S., Su K.W., Kim A., Narayan K., Khoruzhenko S., Xu M., Sadegh-Nasseri S. Short peptide sequences mimic HLA-DM functions. Mol Immunol 2008, 45:1935-1943.
35. Prinz H., Striessnig J. Ligand-induced accelerated dissociation of (+)-cis-diltiazem from L-type Ca2+ channels is simply explained by competition for individual attachment points. J Biol Chem 1993, 268:18580-18585.
36. Kim B., Eggel A., Tarchevskaya S.S., Vogel M., Prinz H., Jardetzky T.S. Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor. Nature 2012, 491:613-617.
37. Gu Y., Jensen P.E., Chen X. Immunodeficiency and autoimmunity in H2-O-deficient mice. J Immunol 2013, 190:126-137.
38. Liljedahl M., Winqvist O., Surh C.D., Wong P., Ngo K., Teyton L., Peterson P.A., Brunmark A., Rudensky A.Y., Fung-Leung W.P., et al. Altered antigen presentation in mice lacking H2-O. Immunity 1998, 8:233-243.
39. Alfonso C., Williams G.S., Karlsson L. H2-O influence on antigen presentation in H2-E-expressing mice. Eur J Immunol 2003, 33:2014-2021.
40. Alfonso C., Williams G.S., Han J.O., Westberg J.A., Winqvist O., Karlsson L. Analysis of H2-O influence on antigen presentation by B cells. J Immunol 2003, 171:2331-2337.
41. van Ham S.M., Tjin E.P., Lillemeier B.F., Gruneberg U., van Meijgaarden K.E., Pastoors L., Verwoerd D., Tulp A., Canas B., Rahman D., et al. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr Biol 1997, 7:950-957.
42. Perraudeau M., Taylor P.R., Stauss H.J., Lindstedt R., Bygrave A.E., Pappin D.J., Ellmerich S., Whitten A., Rahman D., Canas B., et al. Altered major histocompatibility complex class II peptide loading in H2-O-deficient mice. Eur J Immunol 2000, 30:2871-2880.
43. Yi W., Seth N.P., Martillotti T., Wucherpfennig K.W., Sant'Angelo D.B., Denzin L.K. Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence. J Clin Invest 2010, 120:1324-1336.
44. Kremer A.N., van der Meijden E.D., Honders M.W., Goeman J.J., Wiertz E.J., Falkenburg J.H., Griffioen M. Endogenous HLA class II epitopes that are immunogenic in vivo show distinct behavior toward HLA-DM and its natural inhibitor HLA-DO. Blood 2012, 120:3246-3255.
45. Pezeshki A.M., Azar G.A., Mourad W., Routy J.P., Boulassel M.R., Denzin L.K., Thibodeau J. HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides. Hum Immunol 2013, 74:1280-1287.
46. Poluektov Y.O., Kim A., Hartman I.Z., Sadegh-Nasseri S. HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation. PLoS ONE 2013, 8:e71228.
47. Deshaies F., Brunet A., Diallo D.A., Denzin L.K., Samaan A., Thibodeau J. A point mutation in the groove of HLA-DO allows egress from the endoplasmic reticulum independent of HLA-DM. Proc Natl Acad Sci U S A 2005, 102:6443-6448.
48. Gondre-Lewis T.A., Moquin A.E., Drake J.R. Prolonged antigen persistence within nonterminal late endocytic compartments of antigen-specific B lymphocytes. J Immunol 2001, 166:6657-6664.
49. Zwart W., Griekspoor A., Kuijl C., Marsman M., van Rheenen J., Janssen H., Calafat J., van Ham M., Janssen L., van Lith M., et al. Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape. Immunity 2005, 22:221-233.
50. Xiu F., Cote M.H., Bourgeois-Daigneault M.C., Brunet A., Gauvreau M.E., Shaw A., Thibodeau J. Cutting edge: HLA-DO impairs the incorporation of HLA-DM into exosomes. J Immunol 2011, 187:1547-1551.
51. Jahnke M., Trowsdale J., Kelly A.P. Ubiquitination of HLA-DO by MARCH family E3 ligases. Eur J Immunol 2013, 43:1153-1161.
52. Morgan M.A., Muller P.S., Mould A., Newland S.A., Nichols J., Robertson E.J., Cooke A., Bikoff E.K. The nonconventional MHC class II molecule DM governs diabetes susceptibility in NOD mice. PLoS ONE 2013, 8:e56738.
53. Mohan J.F., Unanue E.R. Antigen presentation events in autoimmune diabetes. Nat Rev Immunol 2012, 12:721-728.
54. Mohan J.F., Levisetti M.G., Calderon B., Herzog J.W., Petzold S.J., Unanue E.R. Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes. Nat Immunol 2010, 11:350-354.
55. Sirota M., Schaub M.A., Batzoglou S., Robinson W.H., Butte A.J. Autoimmune disease classification by inverse association with SNP alleles. PLoS Genet 2009, 5:e1000792.